Loading stock data...

Shree Pacetronix Limited

BSE: SHREEPAC

BSE
171.35 15.55 (9.98%)

Prev Close

155.8

Open Price

151.1

Volume

19,609

Today Low / High

145.3 / 171.35

52 WK Low / High

61.11 / 283.15

Range

163 - 180

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 171.35, reflecting a change of 15.55 (9.98074%). The expected target range on the BSE is 163 - 180. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

02 Jan 182.20 -5.35%
01 Jan 181.65 -0.08%
31 Dec 209.70 -9.49%
30 Dec 182.90 9.21%
29 Dec 202.95 -5.15%
26 Dec 220.00 -7.91%
24 Dec 201.00 6.04%
23 Dec 218.35 -6.94%
22 Dec 214.30 -0.21%
19 Dec 215.00 -0.33%
18 Dec 226.05 -0.22%
17 Dec 237.40 0.00%
16 Dec 268.60 -6.98%
15 Dec 270.50 -2.79%
12 Dec 271.00 0.15%
11 Dec 268.00 0.71%
10 Dec 275.50 -3.54%

Shree Pacetronix Limited Graph

Shree Pacetronix Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Shree Pacetronix Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 171.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 171.35 173.06 155.76 - 190.37
174.78 139.82 - 209.73
176.49 123.54 - 229.44
Bearish Scenario 171.35 169.64 152.67 - 186.60
167.92 134.34 - 201.51
166.21 116.35 - 216.07

Overview of Shree Pacetronix Limited

ISIN

INE847D01010

Industry

Medical - Specialties

Vol.Avg

10,638

Market Cap

620,716,530

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

103.65

DCF

75

Financial Ratios Every Investor Needs

Stock Dividend of SHREEPAC

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2007-09-24 September 24, 07 0.5 0.5
2003-10-29 October 29, 03 0.4 0.4

Stock Rating Details for SHREEPAC

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 3 Neutral
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 16.80 Cr 5.54 Cr 11.27 Cr 0.6704 0.00 Cr 4.87 Cr 1.50 Cr 0.75 Cr 2.09 2.43 Cr 0.0446
2024-03-31 22.04 Cr 8.20 Cr 14.71 Cr 0.6675 0.69 Cr 0.81 Cr 5.01 Cr 3.36 Cr 9.33 5.94 Cr 0.1524
2023-03-31 20.26 Cr 7.54 Cr 12.72 Cr 0.6280 0.67 Cr 0.74 Cr 4.92 Cr 3.26 Cr 9.06 5.54 Cr 0.1609
2022-03-31 9.23 Cr 3.61 Cr 5.62 Cr 0.6088 0.23 Cr 0.35 Cr 1.28 Cr 0.78 Cr 2.17 1.85 Cr 0.0846
2021-03-31 7.56 Cr 3.03 Cr 1.99 Cr 0.2635 0.23 Cr 0.36 Cr 0.43 Cr 0.05 Cr 0.15 0.99 Cr 0.0070

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.25 Cr 23.05 Cr 9.26 Cr 13.7816 Cr 5.07 Cr 4.82 Cr 7.03 Cr 4.71 Cr 0.00 Cr 0.00 Cr 0.41 Cr 8.8660 Cr
2024-03-31 0.11 Cr 21.75 Cr 8.71 Cr 13.0316 Cr 4.30 Cr 4.19 Cr 5.74 Cr 5.08 Cr 1.35 Cr 0.04 Cr 0.33 Cr 8.1326 Cr
2023-03-31 0.07 Cr 16.54 Cr 6.87 Cr 9.6735 Cr 2.19 Cr 2.12 Cr 2.98 Cr 4.69 Cr 1.63 Cr 0.04 Cr 0.30 Cr 6.4746 Cr
2022-03-31 0.89 Cr 12.18 Cr 5.76 Cr 6.4139 Cr 3.04 Cr 2.15 Cr 1.66 Cr 4.12 Cr 1.15 Cr 0.04 Cr -0.23 Cr 5.1419 Cr
2021-03-31 0.77 Cr 10.98 Cr 5.35 Cr 5.6332 Cr 3.20 Cr 2.43 Cr 1.96 Cr 4.25 Cr 0.64 Cr 0.04 Cr 0.09 Cr 4.6287 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.0079 Cr -0.0413 Cr 0.1892 Cr -0.7246 Cr 0.1400 Cr 0.2542 Cr -0.7167 Cr 1.0431 Cr 0.7710 Cr 0.0000 Cr -1.2839 Cr
2024-03-31 -0.3338 Cr -1.7367 Cr 2.1135 Cr -1.4136 Cr 0.0430 Cr 0.1142 Cr -1.3780 Cr 3.3581 Cr 2.1135 Cr 0.0000 Cr -2.7594 Cr
2023-03-31 1.7424 Cr -1.4149 Cr -1.1505 Cr 0.5080 Cr -0.8230 Cr 0.0713 Cr -1.2344 Cr 4.6203 Cr -0.8547 Cr 0.0000 Cr -1.3229 Cr
2022-03-31 1.7613 Cr -1.1877 Cr -0.4499 Cr 1.3547 Cr 0.1237 Cr 0.8943 Cr -0.4066 Cr 1.0605 Cr -0.1566 Cr 0.0000 Cr 0.2935 Cr
2021-03-31 1.0885 Cr -0.5309 Cr -0.3121 Cr 0.3260 Cr 0.2455 Cr 0.7706 Cr -0.7625 Cr 0.1319 Cr 0.0406 Cr 0.0000 Cr 0.0423 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 6.59 Cr 1.96 Cr 4.63 Cr 0.7030 1.82 Cr 1.31 Cr 3.64 2.04 Cr 0.1988
2025-06-30 5.34 Cr 1.70 Cr 3.64 Cr 0.6811 0.98 Cr 0.66 Cr 1.85 1.18 Cr 0.1244
2025-03-31 4.28 Cr 1.36 Cr 2.92 Cr 0.6834 0.77 Cr 0.45 Cr 1.26 1.01 Cr 0.1063
2024-12-31 3.63 Cr 1.20 Cr 2.42 Cr 0.6685 -0.03 Cr -0.11 Cr -0.31 0.16 Cr -0.0306
2024-09-30 4.04 Cr 2.69 Cr 1.36 Cr 0.3351 0.19 Cr 0.03 Cr 0.09 0.42 Cr 0.0083

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.29 Cr 0.98 Cr 1.28 Cr 8.82 Cr 5.49 Cr 19.51 Cr 4.46 Cr 25.37 Cr 9.62 Cr
2025-06-30 0.00 Cr 0.00 Cr 1.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -13.78 Cr
2025-03-31 0.25 Cr 0.86 Cr 1.16 Cr 6.68 Cr 7.03 Cr 17.19 Cr 4.71 Cr 23.05 Cr 9.26 Cr
2024-12-31 0.00 Cr 0.00 Cr 1.22 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -13.44 Cr
2024-09-30 0.20 Cr 1.02 Cr 1.22 Cr 6.00 Cr 7.55 Cr 18.76 Cr 4.70 Cr 24.84 Cr 11.40 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 0.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.45 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.11 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Regional Manager
Advik Sharma

Gender: Not Specified

Year Born: 1993

Joint MD & Executive Director
Akash Sethi

Gender: male

Year Born: 1991

Chief Financial Officer
Ashok Atulkar

Gender: male

Year Born:

MD & Executive Chairman
Atul Kumar Sethi

Gender: male

Year Born: 1962

Regional Sales Manager
Murtaza Faizee

Gender: male

Year Born: 1974

Territory Sales Manager
Neeraj Tiwari

Gender: male

Year Born: 1991

Assistant Quality Control
Pradip Tyagi

Gender: male

Year Born: 1986

Sales Manager
Rabin Chakraborty

Gender: male

Year Born: 1965

Chief Operating Officer & Regional Marketing Manager
Sumit Chakarbarti

Gender: male

Year Born: 1958

Company Secretary & Compliance Officer
Rupali Ahire

Gender: female

Year Born:

FAQs about Shree Pacetronix Limited

Who is the CEO of the company?

The CEO is Atul Kumar Sethi.

What is the current market price of the stock?

The current price is ₹172.45.

What is the 52-week price range?

The range is ₹61.11-283.15.

What is the market capitalization of the company?

The market capitalization is ₹62.07 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 26.77.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Shree Pacetronix Limited (ISIN: INE847D01010) is a leading Medical - Specialties in India. With a market capitalization of ₹62.07 crores and an average daily volume of 10,638 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.